Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer [clinicaltrials:NCT00057889]
Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer [clinicaltrials:NCT00057889]
Bio2RDF identifier
NCT00057889
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00057889
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Monoclonal a ...... e treated with interleukin-2.
brief title [clinicaltrials_vocabulary:brief-title]
Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2008-02-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES:
- ...... study within 2-4
years.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2003-04-07T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
keyword [clinicaltrials_vocabulary:keyword]
clear cell renal cell carcinoma
recurrent renal cell cancer
stage IV renal cell cancer
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2012-03-14T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct alias [clinicaltrials_vocabulary:nct-alias]
NCT00053729
nct id [clinicaltrials_vocabulary:nct-id]
NCT00057889
official title [clinicaltrials_vocabulary:official-title]
A Phase II Open-Label Study of ...... nts With Stage IV Renal Cancer
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2007-10-01T00:00:00Z
secondary id [clinicaltrials_vocabulary:secondary-id]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2003-02-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2012-03-01T00:00:00Z
identifier
clinicaltrials:NCT00057889
title
Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer
@en
type
label
Monoclonal Antibody Therapy in ...... r [clinicaltrials:NCT00057889]
@en